Synthesis of 1,1´-[methylenebis(oxy)]bis[3-alkyl-3-(2-haloethyl)triaz-1-ene 2-oxides]

A method for the synthesis of promising nitric oxide donors in living organisms, 1,1´-[methylenebis(oxy)]bis[3-alkyl-3-(2-haloethyl)triaz-1-ene 2-oxides] was elaborated. The method involved replacement of hydroxy groups of the corresponding 1,1´-[methylenebis(oxy)]bis[3-alkyl-3-(2-hydroxyethyl)triaz-1-ene 2-oxides] by halogen atoms and, in some cases, the exchange of one halogen atom for another.     

[(enH)2(enH2)Sn2Se6]的合成、结构及性能研究

采用溶剂热法,以K2Se:SnCl2·2H2O∶Se∶en=1∶1∶4∶48的摩尔比,在150 ℃下反应5d,生成黄色透明柱状晶体[(enH2)2Sn2Se6·en]。该晶体属于三斜晶系 ,空间群为Pl^-,晶胞参数,a=0.8659(2)nm,b=1.1055(2)nm,c=0.66360(10)nm, a=104.44(3)°,β=110.93(3)°,γ=79.74(3)°,V=0.57198(19)nm^3,Z=1.[ (enH2)Sn2Se6]晶体由质子化的乙二胺正离子（enH)^+,(enH2)^2+和二聚硒代锡根 负离子（Sn2Se6)^4-堆积而成。在AxSn2Se6系列化合物,正离子A的大小对晶体结 构的类型产生重要的影响。研究表明,此晶体具有1.76eV的能隙（Eg）,是个半导 体,对太阳辐射具有选择吸收特性,在温度低于180℃时是稳定的。     

Synthesis of substituted pyrido[3´,2´:4,5]thieno[3,2-c]isoquinolin-5(6H)-ones and their sulfinyl and sulfonyl derivatives

A method for the synthesis of previously unknown pyrido[3´,2´:4,5]thieno[3,2-c]isoquinolin-5(6H)-ones was suggested, which includes a condensation reaction of substituted 3-cyanopyridine-2(1H)-thiones with methyl 2-(chloromethyl)benzoate and subsequent treatment of the condensation products with potassium tert-butoxide. The oxidation of the condensation products to sulfoxides or sulfones and subsequent treatment of these compounds with potassium tert-butoxide led to substituted pyrido[3´,2´:4,5]thieno[3,2-c]isoquinolin-5(6H)-one 11-oxides or substituted pyrido[3´,2´:4,5]thieno[3,2-c]isoquinolin-5(6H)-one 11,11-dioxides.

     

Synthesis of cobalt bis(8-methylthio-1,2-dicarbollide)- pentacarbonyltungsten complexes

Russian Chemical Bulletin - A reaction of Bu4N[8,8´-(MeS)2-3,3´-Co(1,2-C2B9H10)2] with (MeCN)3W(CO)3 in dichloromethane gave a mixture of...     

Reaction of Dimethyl Sulfoxide with 4-Acyloxycoumarins

Dimethyl sulfoxide converts 4-acetoxycoumarin (1) exclusively to 2-(2-hydroxybenzoyl)-2-[(methylthio)methyl]-2,3-dihydro-4 H-furo[3,2-c]chromen-4-one (3) at 180°C under a nitrogen atmosphere, but in the absence of nitrogen, the products obtained are dicoumarol and its dehydrative cyclization products 7 H-bis[1]benzopyrano[4,3-b: 3′,4′-c]pyran-6,8-dione (9) and (3). Under similar conditions, 4-benzoyloxycoumarin (1a) affords benzoic acid, 4-hydroxy-3-({2-[(methylthio)methyl]-3-oxo-2,3-dihydro-1-benzofuran-2-yl}methyl)-2H-chromen-2-one (7), and 3-(2-hydroxybenzoyl)-3,4-dihydro-2H,5H-pyrano[2,3-b] chromen-5-one (8).     

Photochromic transformations of amphiphilic spiropyran in acetonitrile solutions and at the air/water interface

Russian Chemical Bulletin - The results of a study of the photochromic properties of 1´-hexadecyl-3´,3´-dimethyl-6-nitro-1´,3´-dihydrospiro[chromene-2,2´-indole] (SP)...     

Aminolysis of 2-Aryl-5-R-5,6-dihydro-7H-[1,2,4]triazolo[5,1-<Emphasis Type="Italic">b</Emphasis>]1,3]thiazin-7-ones

We have established that the products of aminolysis of 2-aryl-5-R-5,6-dihydro-7H-[1,2,4]triazolo-[5,1-b][1,3]thiazin-7-ones in boiling ethanol are 3-R-3-(5-aryl-4H-1,2,4-triazol-3-ylsulfanyl)-propanamides, and at 180°C–210°C (depending on the structure of the substituent R): 3-phenyl-4,5-dihydro-1H-1,2,4-triazoline-5-thione and 3-arylacrylamides or 3-(3-aryl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)propanamides. __________ Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 10, pp. 1587–1592, October, 2005.     

Oxazoline derivatives of [17(20)<Emphasis Type="Italic">E</Emphasis>]-21-norpregnene – inhibitors of CYP17A1 activity and proliferation of prostate carcinoma cells

Nine new oxazolinyl derivatives of [17(20)E]-21-norpregnene, differing in the structure of steroid moiety, were investigated for their potency to inhibit the CYP17A1 catalytic activity, as well as growth and proliferation of LNCaP and PC-3 prostate carcinoma cell lines. The activity of one of the investigated compounds, 2´-{[(E)3β-hydroxyandrost-5-en-17-ylidene]methyl}-4´,5´-dihydro-1´,3´-oxazole (1), was found to be comparable with that of Abiraterone, a known inhibitor of CYP17A1 used for treatment of prostate cancer. A model of the interaction of oxazoline 1 with the active site of CYP17A1 was constructed by the molecular dynamics method. A correlation was found between the structure and the biological activity in the series of [17(20)E]-21-norpregnene oxazolinyl derivatives.     

Synthesis of methyl 7-aryl-6-(2-thenoyl)-4,7-dihydro-tetrazolo[1,5-<Emphasis Type="Italic">a</Emphasis>]pyrimidine-5-carboxylates and their reaction with hydrazine hydrate

Fusion of methyl 4-(2-thienyl)-2,4-dioxobutanoate with 1H-tetrazol-5-amine monohydrate and aromatic aldehyde gave methyl 7-aryl-6-(2-thenoyl)-4,7-dihydrotetrazolo[1,5-a]pyrimidine-5-carboxylates which reacted with an equimolar amount of hydrazine hydrate at 180–190°C under solvent-free conditions to produce 9-aryl-8-(2-thienyl)-4,9-dihydrotetrazolo[1′,5′: 1,2]pyrimido[4,5-d]pyridazin-5(6H)-ones.     

Cadmium(II) complexes with monoiodo- and dibromodipyrromethenes: synthesis,molecular structure,spectral-luminescent properties,and stability in solutions

Cadmium(II) chelates with 4-iodo-, 5,5´-, and 4,4´-dibromo-2,2´-dipyrromethenes (HL¹, HL², and HL³, respectively) with the composition of [CdL₂] were synthesized. The influence of structural features of their molecules and properties of the medium on the characteristics of absorption and fluorescence spectra, and also on the thermodynamic stability constants in solutions was evaluated. The results of quantum chemical calculations revealed that the additional coordination interactions between the bromine atoms at the α-positions of dipyrromethene ligands and the complexing atom are possible in the molecular structure of α,α´- dibromosubstituted dipyrromethenate [Cd(L²)₂] in contrast with β-halogenated analogues [Cd(L¹)₂] and [Cd(L³)₂].     

Synthesis and pharmacological activity of silyl isoxazolines 2

Silyl isoxazolines have been synthesized by [2+3] cycloaddition reaction of nitrile oxides to vinyl- and allylsilanes. The addition of 3-pyridylnitrile oxide to 1,3-divinyl-1,1,3,3-tetraphenyldisiloxane affords 1,3-bis{5-[3-(3-pyridyl)isoxazolin-2-yl]}-1,1,3,3-tetraphenyldisiloxane; the latter exists as a mixture of trans- and cis-isomers.The bond angle of the Si–O–Si fragment in thetrans-isomer equals 180(3)° and in the cis-isomer it is 162(3)°.The pharmacological properties of 4-[3-(5-trimethylsilylisoxazolin-2-yl)]pyridinium-chloride have been studied.     

The Homoconjugated Electron-Releasing Carbonyl Group of 1-Methylbicyclo[2.2.1]hept-5-en-2-one. Regioselective syntheses of 5-chloro- and 6-chloro-1-methylbicyclo[2.2.1]hept-5-en-2-one

Syntheses of (±)-2-exo-cyano-1-methyl-7-oxabicyclo[2.2.1]hept-5-en-2-endo-yl acetate ( 1 ) and of (±)-1-methyl-7-oxabicyclo[2.2.1]hept-5-en-2-one ( 2 ) are reported. The additon of PhSeCl to 1 afforded (±)-5-endo-chloro-2-exo-cyano-1-methyl-6-exo-(phenylselenenyl)-7-oxabicyclo[2.2.1]hept-2-endo-yl acetate ( 6 ), whereas 2 added to PhSeCl with the opposite regioselectivity giving (±)-6-endo-chloro-1-methyl-5-exo-(phenylselenenyl)-7-oxabicyclo[2.2.1]heptan-2-one ( 7 ). These adducts were converted into 5-chloro-1-methyl-7-oxabicyclo[2.2.1]hept-5-en-2-one ( 9 ) and 6-chloro-1-methyl-7-oxabicyclo[2.2.1]hept-5-en-2-one ( 10 ), respectively.     

Enamines derived from the reactions of 2-amino-3-(o-bromobenzyloxy)pyridine with esters of acetoacetic and β-aminocrotonic acids. Enamines as intermediates in the formation of 4H-pyrido[1,2-a]pyrimidin-4-ones

Two stable crystalline enamines, 10 and 11 , have been isolated from the reactions of 2-amino-3-(o-bromobenzyloxy)pyridine, 4 , with esters of acetoacetic or β-aminocrotonic acids. The formation of 10 and 11 occurred in the absence of a solvent or in diethylbenzene at 100–175°, and was always accompanied by the formation of the cyclized derivative, 9-(o-bromobenzyloxy)-2-methylpyrido[1,2-a]pyrimidin-4-one, 12. Molecular models, ir, and pmr spectra were employed to establish the structure of the enamines and to demonstrate that in solution, 10 and 11 existed as six-membered chelate structures, with intramolecular hydrogen bonding between the NH proton and the ester carbonyl oxygen atom. The thermal cyclization of 10 and 11 to 12 occurred under a variety of conditions: (a) in diethylbenzene at 170–175°, (b) fusion at 175–180° under atmospheric pressure, or (c) heating at 175–180°/1 mm, thus suggesting that an enamine is the intermediate in cyclization reactions that lead to the formation of pyrido [1,2-a]pyrimidin-4-ones.     

Intramolecular cyclization of 1,3-diamino-2-hydroxypropan-N,N,N´,N´-tetrakis(methylphosphonic acid) upon phosphonomethylation of 1,3-diaminopropan-2-ol

Phosphonomethylation of 1,3-diaminopropan-2-ol affords the mixture of 1,3-diamino-2-hydroxypropan-N,N,N´,N´-tetrakis(methylphosphonic acid) (1) with its cyclic ether, viz., [(6-[bis(phosphonomethyl)amino]methyl-2-hydroxy-2-oxido-1,4,2-oxazaphosphinan-4-yl)methyl]phosphonic acid (2), but not 1, as assumed earlier.

     

TiO_2/Na_2SO_3体系中日光催化聚合甲基丙烯酸甲酯的研究

在密闭空气和日光连续照射下 ,考察了TiO2 Na2 SO3 体系中MMA的聚合行为 ,结果显示 ,在TiO2 的零电荷点处 ,日光可引发聚合甲基丙烯酸甲酯 ,诱导期为 2～ 15min ,主要受pH的控制 .当 [TiO2 ]=(5 .0～ 7.0 )× 10 - 5mol·L- 1 ,[Na2 SO3]=(1.0～ 1.5 6 )× 10 - 3 mol·L- 1 ,[MMA]=(3.74～ 10 .7)× 10 - 2 mol·L- 1 时 ,表观聚合速率Rp=k·e- 1 1 4 .80 0 RT·[MMA]0 .94[IA]0 .50 [Na2 SO3]0 .55[TiO2 ]1 .0 6 ,所得聚合物平均分子量为 12 0× 10 5,最高产率达 95 % ,聚合按自由基机理进行     

Effect of counteranion X on the spin crossover properties of a family of diiron(II) triazole complexes [Fe(II)2(PMAT)2](X)4

Seven diiron(II) complexes, [Fe(II)(2)(PMAT)(2)](X)(4), varying only in the anion X, have been prepared, where PMAT is 4-amino-3,5-bis{[(2-pyridylmethyl)-amino]methyl}-4H-1,2,4-triazole and X = BF(4)(-) (1), Cl(-) (2), PF(6)(-) (3), SbF(6)(-) (4), CF(3)SO(3)(-) (5), B(PhF)(4)(-) (6), and C(16)H(33)SO(3)(-) (7). Most were isolated as solvates, and the microcrystalline ([3], [4]·2H(2)O, [5]·H(2)O, and [6]·?MeCN) or powder ([2]·4H(2)O, and [7]·2H(2)O) samples obtained were studied by variable-temperature magnetic susceptibility and Mo?ssbauer methods. A structure determination on a crystal of [2]·2MeOH·H(2)O, revealed it to be a [LS-HS] mixed low spin (LS)-high spin (HS) state dinuclear complex at 90 K, but fully high spin, [HS-HS], at 293 K. In contrast, structures of both [5]·?IPA·H(2)O and [7]·1.6MeOH·0.4H(2)O showed them to be [HS-HS] at 90 K, whereas magnetic and M?ssbauer studies on [5]·H(2)O and [7]·2H(2)O revealed a different spin state, [LS-HS], at 90 K, presumably because of the difference in solvation. None of these complexes undergo thermal spin crossover (SCO) to the fully LS form, [LS-LS]. The PF(6)(-) and SbF(6)(-) complexes, 3 and [4]·2H(2)O, appear to be a mixture of [HS-LS] and [HS-HS] at low temperature, and undergo gradual SCO to [HS-HS] on warming. The CF(3)SO(3)(-) complex [5]·H(2)O undergoes gradual, partial SCO from [HS-LS] to a mixture of [HS-LS] and [HS-HS] at T(1/2) ≈ 180 K. The B(PhF)(4)(-) and C(16)H(33)SO(3)(-) complexes, [6]·(1)/(2)MeCN and [7]·2H(2)O, are approximately [LS-HS] at all temperatures, with an onset of gradual SCO with T(1/2) > 300 K.     

Organoboron compounds : CCCXCIX. The matteson-pasto rearrangement in the series of 3-borabicyclo[3.3.1]nonane compounds

Bromination of 3-isopropyl-7-methyl- and 3-isopropyl-7-bromomethyl-3-borabicyclo[3.3.1]nonane leads to corresponding 3-(2-bromo-2-propyl) derivatives, which, on treatment with alcohols or pyridine as well as on heating, undergo the Matteson-Pasto rearrangement to convert into 3-X-4,4,8-trimethyl- and 3-X-4,4-dimethyl-8-bromomethyl-3-borabicyclo[4.3.1]decane (X = Br, OR). Interaction between triethylamine and 3-(2-bromo-2-propyl)-7-methyl-3-borabicyclo[3.3.1]nonane is accompanied by dehydrobromination leading to 3-isopropenyl-7-methyl-3-borabicyclo[3.3.1]nonane. Carbonylation of 3,4,4,8-tetramethyl-3-borabicyclo[4.3.1]decane at 140°C is accompanied by migration of two alkyl groups from the boron to the carbon atom, and subsequent oxidation with H₂O₂ produces 1-(2-hydroxy-2-methyl-1-propyl)-3-acetonyl-5-methyl-cyclohexane. Under more forcing conditions (180-195°C), the third alkyl group also migrates to give, after oxidation, a mixture of isomeric 3,4,4,8-tetramethylbicyclo[4.3.1]decan-3-ols. 3-n-Butoxy-4,4-dimethyl-8-bromomethyl-3-borabicyclo[4.3.1]decane, on treatment with Lì, undergoes cyclization to afford 4,4-dimethyl-3-borahomoadamantane, carbonylation and subsequent oxidation of which gave 4,4-dimethylhomoadamantan-3-ol.     

Partially fluorinated heterocyclic compounds. Part 15 [1]. Further preparations of furan derivatives from pentafluorophenyl- and 1,3,4,5,6,7,8-heptafluoro-2-naphthyl prop-2-ynyl ethers. The isolation of the claisen rearrangement intermediate 1,3,4,5,6,7,8-heptafluoro-1-(propa-1,2-dienyl)-naphthalen-2-one

1,3,4,5,6,7,8-Heptafluoro-2-naphthyl prop-2-ynyl ether (5) and boiling isopropylbenzene gives 1,3,4,5,6,7,8-heptafluoro-1-(propa-1,2-dienyl)naphthalen-2-one (9) and two isomeric 2-(isopropylbenzyl)-4,5,6,7,8,9-hexafluoronaphtho [2,1-b]furans (11). Di-(4,5,6,7,8,9-hexafluoronaphtho [2,1-b]furan-2-ylmethyl) ether (17) and bis-(4,5,6,7,8,9-hexafluoronaphtho [2,1-b]furan-2-y1)methane (18) are formed from (5) in CF₂ClCFCl₂ at 137°. The solvolysis of 2-fluoromethyl-4,5,6,7,8,9-hexafluoronaphtho-[2,1-b]furan (10) in water at 145–156° yields (17) (2%), (18) (37%) and 4,5,6,7,8,9-hexafluoronaphtho[2,1-b]furan-2-ylmethyl alcohol (19) (13%). Pentafluorophenyl prop-2-ynyl ether (1) reacts in either C₆F₆ or CF₂ClCFCl₂ at 140° to give di-(4,5,6,7-tetrafluorobenzo [b] furan-2-ylmethyl) ether (15). The major product from the solvolysis of 2-fluoromethyl-4,5,6,7-tetra-fluorobenzo [b] furan (2) in water at 140–142° is 4,5,6,7-tetra-fluorobenzo [b] furan-2-ylmethyl alcohol (16) (87%) accompanied by (15) (2.5%).     

含氧桥的笼状化合物[Mo_5P_2O_(23)]~(6-)[(CH_3)_2NH_2]_5~(5+)-[H_3O]~+·1/2(CH_3)_2NCHo·1/2H_2O的合成和结构

[Mo_5P_2O_(23)]~(6-)[(CH_3)_2NH_2]_5~(5+)[H_3O]~+·1/2DMF·1/2H_2O(DMF=(CH_3)_2NC-HO)(M_r=1204.67)的晶体属三斜晶系,空间群P,晶胞参数a=16.438(6);b=22.22(1);c=11.325(5),α=104.25(4);β=108.97(3);γ=97.68(4)°,V=3688(3),Z=4,D_c=2.17gcm~(-1),R=0.056,R_w=0.074,晶胞中每个不对称单元含有两个[Mo_5P_2O_(23)]~(6-)[(CH_3)_2NH_2]_5~(5+)[H_3O]~+·1/2DMF·1/2H_2O,阴离子[Mo_5P_2O_(23)]~(6-)中的Mo、P原子成一个畸变五角双锥构型。有一个阴离子的所有原子(Mo、P、O)位置完全确定,而另一个阴离子有一个磷酸根的三个氧原子位置出现二重位置统计分布。化合物的阳离子为二甲胺阳离子和水合氢离子。     

18F-labeled pyrazolo[1,5-a]pyrimidine derivatives: synthesis from 2,4-dinitrobenzamide and tosylate precursors and comparative biological evaluation for tumor imaging with positron emission tomography

We previously reported 18F-labeled pyrazolo[1,5-a]pyrimidine derivatives: 7-(2-[18F]fluoroethylamino)-5-methylpyrazolo[1,5-a]pyrimidine-3-carbonitrile ([18F]1) and N-(2-(3-cyano-5-methylpyrazolo[1,5-a]pyrimidin-7-ylamino)ethyl)-2-[18F]fluoro-4-nitro- benzamide ([18F]2). Preliminary biodistribution experiments of both compounds showed s slow clearance rate from excretory tissues which warranted further investigation for tumor imaging with PET. Here we modified [18F]1 and [18F]2 by introducing polar groups such as ester, hydroxyl and carboxyl and developed three additional 18F-18 labeled pyrazolo[1,5-a] pyrimidine derivatives: (3-Cyano-7-(2-[18F]fluoroethylamino)pyrazolo[1,5-a]-pyrimidin-5- yl)methyl acetate ([18F]3), 7-(2-[18F]fluoroethylamino)-5-(hydroxymethyl)pyrazolo[1,5-a]- pyrimidine-3-carbonitrile ([18F]4) and (S)-6-(3-cyano-5-methylpyrazolo[1,5-a]pyrimidin-7-ylamino)-2-(2-[18F]fluoro-4-nitrobenzamido)hexanoic acid ([18F]5). The radiolabeled probes were synthesized by nucleophilic substitution of the corresponding tosylate and nitro precursors with 18F-fluoride. In Vitro studies showed higher uptake of [18F]3 and [18F]4 than that of [18F]5 by S180 tumor cells. In Vivo biodistribution studies in mice bearing S180 tumors showed that the uptake of both [18F]3 and [18F]4 in tumors displayed an increasing trend while the uptake of [18F]5 in tumor decreased through the course of the 120 min study. This significant difference in tumor uptake was also found between [18F]1 and [18F]2. Thus, we compared the biological behavior of the five tracers and reported the tumor uptake kinetic differences between 2-[18F]fluoroethylamino- and 2-[18F]fluoro-4-nitro- benzamidopyrazolo[1,5-a] pyrimidine derivatives.